Search
Add filters:
Use filters to refine the search results.
Item hits:
Issue Date | Title | Author(s) |
---|---|---|
1-Aug-2020 | Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer A Phase 1 and Randomized Phase 2 Trial | Cortés, Javier; Dieras, Veronique; Lorenzen, Sylvie; Montemurro, Filippo; Riera-Knorrenschild, Jorge; Thuss-Patience, Peter; Allegrini, Giacomo; Laurentiis, Michele De; Lohrisch, Caroline; Oravcova, Eva; Pérez García, José Manuel; Ricci, Francesco; Sakaeva, Dina; Serpanchy, Rosanne; Sufliarsky, Jozef; Vidal Losada, Maria Jesús; Irahara, Natsumi; Wohlfarth, Christine; Aout, Mounir; Gelmon, Karen |
1-Dec-2020 | Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial | López Miranda, Elena; Pérez García, José Manuel; Cosimo, Serena Di; Brain, Etienne; Ravnik, Maja; Escrivá de Romaní, Santiago; Vidal Losada, Maria Jesús; Gligorov, Joseph; Borstnar, Simona; Calabuig, Laura; Sampayo-Cordero, Miguel; Malfettone, Andrea; Llombart Cussac, Antonio; Suter, Thomas M.; Cortés, Javier |
23-Apr-2021 | SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer | Pascual, Tomás; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavilá, Joaquin; Pernas, Sònia; Muñoz Mateu, Montserrat; Vidal Losada, Maria Jesús; Margelí Vila, Mireia; Cejalvo Andújar, Juan Miguel; González Farré, Blanca; Espinosa Bravo, Martin; Cruz, Josefina; Salvador Bofill, Francisco Javier; Guerra, Juan Antonio; Luna Barrera, Ana María; Arumi de Dios, Miriam; Esker, Stephen; Fan, Pang-dian; Martínez Sáez, Olga; Villacampa, Guillermo; Paré, Laia; Ferrero Cafiero, Juan M.; Villagrasa, Patricia; Prat Aparicio, Aleix |
1-Oct-2020 | Serum Phospholipids Fatty Acids and Breast Cancer Risk by Pathological Subtype | Lope, Virginia; Guerrero Zotano, Ángel; Casas, Ana; Baena Cañada, José Manuel; Bermejo, Begona; Pérez Gómez, Beatriz; Criado Navarro, Inmaculada; Antolín, Silvia; Sánchez Rovira, Pedro; Ramos Vázquez, Manuel; Antón, Antonio; Castelló, Adela; García Saenz, Jose Angel; Muñoz Mateu, Montserrat; Juan, Ana de; Andrés, Raquel; Llombart Cussac, Antonio; Hernando, Blanca; Franquesa, Rosa María; Caballero, Rosalía; Priego Capote, Feliciano; Martón, Miguel; Pollán, Marina |
7-Apr-2021 | Identification of cell surface targets for CAR-T cell therapies and antibody-drug conjugates in breast cancer | Schettini, Francesco; Barbao, P; Brasó Maristany, Fara; Galván, Patricia; Martínez, Debora; Paré, Laia; Placido, Sabino De; Prat Aparicio, Aleix; Guedán Carrió, Sònia |
8-May-2020 | Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study | Fernández de Larrea Baz, Nerea; Pérez Gómez, Beatriz; Guerrero Zotano, Angel; Casas, Ana Ma.; Bermejo de las Heras, Begoña; Baena Cañada, José Manuel; Antolin, Silvia; Sánchez Rovira, Pedro; Ramos Vázquez, Manuel; García Sáenz, José Ángel; Antón, Antonio; Muñoz Mateu, Montserrat; Juan, Ana de; Jara, Carlos; Chacón, José Ignacio; Arcusa, Angels; Gil Gil, Miguel; Adrover, Encarna; Oltra, Amparo; Brunet, Joan; González, Sonia; Bezares, Susana; Lope, Virginia; Martín, Miguel; Pollán, Marina |
30-Mar-2021 | RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer | Sanz Moreno, Adrián; Palomeras, Sonia; Pedersen, Kim; Morancho, Beatriz; Pascual, Tomás; Galván, Patricia; Benítez, Sandra; Gómez Miragaya, Jorge; Ciscar, Marina; Jimenez, Maria; Pernas, Sònia; Petit, Anna; Soler, María Teresa; Viñas, Gemma; Alsaleem, Mansour; Rakha, Emad A.; Green, Andrew R.; Santamaria, Patricia G.; Mulder, Celine; Lemeer, Simone; Arribas, Joaquín V. (Vicente); Prat Aparicio, Aleix; Puig, Teresa; González Suárez, Eva |
4-Jan-2021 | Clinical, pathological and PAM50 gene expression features of HER2-low breast cancer | Prat Aparicio, Aleix; Schettini, Francesco; Chic Ruché, Núria; Brasó Maristany, Fara; Paré, Laia; Pascual, Tomás; Conte, Benedetta; Martínez Sáez, Olga; Adamo, Barbara; Vidal Losada, Maria Jesús; Fernández Martínez, Aranzazu; González Farré, Blanca; Sanfeliu, Esther; Cejalvo Andújar, Juan Miguel; Perrone, Giuseppe; Sabarese, Giovanna; Zalfa, Francesca; Villagrasa, Patricia; Gavilá, Joaquín; Barrios, Carlos H.; Lluch, Ana; Martín, Miguel; Placido, Sabino De; Barnadas, Esther; Locci, Mariavittoria; Peg, Vicente; Fasan, Roberta |
20-Jan-2020 | Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade | Brasó Maristany, Fara; Griguolo, Gaia; Pascual, Tomás; Paré, Laia; Nuciforo, Paolo; Llombart Cussac, Antonio; Bermejo de las Heras, Begoña; Oliveira, Mafalda; Morales, Serafín; Martínez, Noelia; Vidal Losada, Maria Jesús; Adamo, Barbara; Martínez, Olga; Pernas, Sònia; López, Rafael; Muñoz Mateu, Montserrat; Chic Ruché, Núria; Galván, Patricia; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, Eduardo; Gregorio, Sara; Gomis, Roger R.; Villagrasa, Patricia; Cortés, Javier; Ciruelos, Eva; Prat Aparicio, Aleix |
14-Jul-2020 | ERBB2mRNA expression and response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-positive breast cancer | Griguolo, Gaia; Brasó Maristany, Fara; González Farré, Blanca; Pascual, Tomás; Chic Ruché, Núria; Saurí, Tamara; Kates, Ronald; Gluz, Oleg; Martínez, Débora; Paré, Laia; Tsvetkova, Vassilena; Pesantez, David; Vidal Losada, Maria Jesús; Adamo, Barbara; Muñoz Mateu, Montserrat; Galván, Patricia; Barberá, Laura; Cuatrecasas Freixas, Miriam; Christgen, Mathias; Kreipe, Hans; Monge Escartín, Inés; Villagrasa, Patricia; Soy Muner, Dolors; Giarratano, Tommaso; Dieci, Maria Vittoria; Conte, Pierfranco; Harbeck, Nadia; Guarneri, Valentina; Prat Aparicio, Aleix |